Table 1.
Demographic, clinical and laboratory data of the studied population
| Variables | T1D | T2D |
|---|---|---|
| Age, years | 37.5 ± 12.5 | 59.7 ± 10.4 |
| Age, n (%) (years) | ||
| < 25 | 29 (20.1) | 2(1.0) |
| 25–44 | 67 (46.5) | 16(7.9) |
| 45–64 | 46 (31.9) | 123 (60.6) |
| ≥ 65 | 2 (1.0) | 62 (30.5) |
| Gender, n (%) | ||
| Male | 63 (43.7) | 71(37.9) |
| Female | 81 (56.3) | 132 (65) |
| Self-reported color-race, n (%)a | ||
| White | 73 (50.7) | 77(37.9) |
| Non-White | 71 (49.3) | 126(62.1) |
| Years of school attendance | 12.4 ± 3.1 | 8.4 ± 4.4 |
| Economic statusb | ||
| Low | 95 (66.0) | 123 (60.6) |
| Very low | 10 (6.9) | 34 (16.7) |
| Medium | 31 (21.5) | 18 (8.9) |
| BMI (kg/m2) | 24.6 ± 4.2 | 29.9 ± 5.2 |
| Initial CG (mg/dl) | 195.8 ± 81.4 | 184.1 ± 64.8 |
| Final CG (mg/dl) | 172.7 ± 89.7 | 174.1 ± 70.6 |
| HbA1c (%) | 8.9 ± 1.9 | 8.1 ± 3.2 |
| < 7.0 n (%) | 16 (11.8) | 56(26.6) |
| ≥ 9.0 n (%) | 63(46.3) | 60(29.6) |
| HbA1c, mmol/mol | 74.5 ± 21.0 | 65.3 ± 19.5 |
| Smokers, years; n (%) | 15 (7.5) | 33 (16.2) |
| Drinkers, years; n (%) | 25 (17.4) | 44(21.6) |
| Diabetes treatment; years, n (%) | ||
| Oral drugsc | 48 (23.9) | 190 (93.5) |
| Antihypertensives | 40 (27.8) | 130(64.0) |
| Insulin | 144 (100.0) | 92(45.3) |
| Statins | 35 (24.3) | 124(61.1) |
T1D Type 1 diabetes, T2D Type 2 diabetes. Data are presented as n (%) or means (standard deviation), BMI body mass index, CG capillary glycemia
aNon-White (Mulattos and Blacks)
bMissing: 8 (5.6%) for T1D and 28 (13.8%) for T2D
cThe oral drug used by patiens with T1D was metformin